ArticleSmall methods2025
Advancing Organ-on-Chip Models With a Sacrificial Granular Hydrogel Strategy for Enhanced Permeability and Biomimicry.
Article in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Hydrogel nanofiber-based 3D cell cultures and organoids.Chemical science · 2026Review
- Emerging Regenerative Medicine for Spinal Cord Injury: Spinal Cord Organoids-on-a-Chip.International journal of molecular sciences · 2026Review
- Hybrid hydrogel system integrating thermoresponsive microspheres and KGN-loaded nanofibers enables efficient cartilage matrix regeneration.Regenerative biomaterials · 2026Article
- Advancing Organ-on-Chip Models With a Sacrificial Granular Hydrogel Strategy for Enhanced Permeability and Biomimicry.Small methods · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Infectious diseases such as malaria, leishmaniasis, and human immunodeficiency virus (HIV) involve pathogens with complex life cycles that span multiple organs, including the bone marrow (BM), a niche for latent or cryptic infections. Studying these hidden stages in patients presents significant technical and ethical challenges, underscoring the need for advanced in vitro models such as organ-on-chip (OoC) platforms. While cell-laden hydrogels can replicate tissue-like 3D-microenvironments, their small mesh size may restrict pathogen migration and cell-pathogen interactions, both critical for establishing infection on-chip. To overcome this limitation, this work develops a "reversed" granular hydrogel strategy that creates interconnected microporosity in hydrogels incorporated into organ-on-chip compartments. Sacrificial alginate (ALG) µgels are embedded as porogens in a fibrin-collagen (FIB-COL) precursor inside a custom BM-on-chip and, after crosslinking, are selectively removed by in situ enzymatic/chemical leaching to yield highly porous hydrogels (pFIB-COL). The pFIB-COL supports 3D-cultures of mesenchymal stromal cells, endothelial cells, and erythroblasts. Physical and cellular analyses show reduced flow resistance, enhanced particle and cell permeation, more uniform cell distribution and improved endothelial network formation compared with native FIB-COL. This versatile strategy is readily adaptable to other hydrogel systems, providing a valuable tool for the faithful modeling of infection processes in biomimetic 3D-microenvironments within OoC devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.